## Abstract 4‐[3‐[4‐(2‐Methoxyphenyl)piperazin‐1‐yl]propoxy]‐4‐aza‐tricyclo[5.2.1.02,6]dec‐8‐ene‐3,5‐dione (4), a potent and selective 5‐HT~1A~ agonist, was labeled by ^11^C‐methylation of the corresponding desmethyl analogue 3 with ^11^C‐methyl triflate. The precursor molecule 3 was synthesized fr
Synthesis and Biodistribution of (R,S)-[O-Methyl-11C]-1-[3-(5-Methoxy-1,2,3,4-tetrahydro-1-naphtalenyl)propyl]-4-Phenylpiperazine (PNU-157760), A Putative Radioligand for 5-HT1AReceptors
✍ Scribed by Mario Matarrese; Dmitrij V. Soloviev; Rosa M. Moresco; Valentino Ferri; Pasquale Simonelli; Fulvio Magni; Diego Colombo; Sergio Todde; Assunta Carpinelli; Ferruccio Fazio; Marzia Galli Kienle
- Publisher
- Elsevier Science
- Year
- 1998
- Tongue
- English
- Weight
- 195 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0045-2068
No coin nor oath required. For personal study only.
✦ Synopsis
Racemic 1- [3-(5-methoxy-1,2,3,4-tetrahydro-1-naphtalenyl)propyl]-4-phenylpiperazine (PNU-157760) was labeled with carbon-11 (t 1/2 ϭ 20.4 min) as a putative radioligand for the noninvasive assessment of 5-HT 1A receptors in vivo with positron emission tomography (PET). The radiochemical synthesis consisted of O-methylation of desmethyl precursor with [ 11 C]methyl iodide in the presence of potassium tert-butoxide in DMF. The desmethyl precursor for the radiosynthesis of [ 11 C]PNU-157760, was prepared by a convenient one-step demethylation of PNU-157760 with boron tribromide. (R,S)-[O-Methyl-11 C]-1-[3-(5-methoxy-1,2,3,4-tetrahydro-1-naphtalenyl)propyl]-4-phenylpiperazine with Ͼ99% radiochemical purity was obtained in 30 min with a radiochemical yield of 10 Ϯ 5% (EOS, nondecay corrected) and a specific radioactivity of 2.5 Ϯ 1 Ci/Ȑmol. Biodistribution studies in rats showed that [ 11 C]PNU-157760 readily crosses the blood-brain barrier with a maximum of brain uptake at 30 min after injection; however, the low specific-to-nonspecific binding ratio in vivo as evidenced by the low hippocampus/cerebellum uptake ratio (1.17 at 60 min postinjection) does not make [ 11 C]PNU-157760 a promising radioligand for serotonin 5-HT 1A receptors.
📜 SIMILAR VOLUMES
Molecular imaging and quantification of myocardial b 1 -adrenoceptor (AR) rather than total b-AR density is of great clinical interest since cardiac biopsy studies suggest that myocardial b 1 -AR density is reduced in patients with chronic heart failure whereas cardiac b 2 -AR density may vary. Posi